Chapter XLV

A. Records, information, and data recorded and stored on computerized, electronic data processing equipment, as permitted by this Chapter, shall be periodically, and not less frequently than monthly, duplicated on electronic/magnetic media or converted to hard copy printout, and …

A. Any theft or unexplained loss of controlled substances in the possession of a registrant shall be reported by the registrant to the board, in writing, within 10 days of the date of the registrant's discovery of such theft or loss, but in no event later than 10 days following t…

A. Not later than 10 days following the date on which a registrant terminates, concludes, sells, assigns, or retires from his practice of medicine or ceases dispensation and administration of medications, the registrant shall report the same to the board in writing. Upon completi…

A. A registrant shall immediately report to the board, in writing, any known or reasonably suspected instance of diversion of medications to unauthorized use or possession by any patient or any other person. Notes La. Admin. Code tit. 46 , § XLV-6557 Promulgated by the Department…

A. The rules of this Subchapter govern physician prescription, dispensation, administration, or other use of medications for weight control or weight reduction in the medical treatment of obesity. Notes La. Admin. Code tit. 46 , § XLV-6901 Promulgated by the Department of Health …

A. The reporting requirements imposed by this Subchapter do not relieve a registrant of any other reporting requirements imposed by existing state or federal laws or regulations. B. Any report required by this Subchapter which is also required to be made in substantially the same…

A. A registrant is personally responsible for knowledge of and compliance with the provisions, requirements, and procedures set forth in this Chapter and with knowledge of and compliance with all other federal, state, and local laws and regulations applicable to the purchase, acq…

A. As authorized and mandated by R.S. 37:1747 , the rules of this Chapter prescribe practice and reporting requirements for physicians, podiatrists, physician's assistants, respiratory therapists, and other board-licensed or certified practitioners to protect the public from the …

A. As used in this Chapter, the following terms shall have the meanings specified. Board - the Louisiana State Board of Medical Examiners. Body Fluids - amniotic, pericardial, peritoneal, pleural, synovial, and cerebrospinal fluids, semen, vaginal secretions, and other body fluid…

A. Except as may be permitted pursuant to § 6709 of this Chapter, a practitioner who is HBsAg seropositive or HIV seropositive, or who otherwise knows or should know that he or she carries and is capable of transmitting HBV or HIV, shall not thereafter perform or participate dire…

A. Conditions. Notwithstanding the prohibition of § 6707 of this Chapter, an HBsAg or HIV seropositive practitioner may nonetheless perform or participate in an exposure-prone procedure with respect to a patient when each of the following four conditions is met. 1. The practition…

A. Applicability. Any practitioner who in the course of practice may at any time undertake to perform or participate in an exposure-prone procedure and who is or becomes HBsAg seropositive or HIV seropositive shall give notice of such seropositivity to the board in accordance wit…

A. General Confidentiality. Reports and information furnished to the board pursuant to § 6711 of this Chapter and records of the board relative to such information shall not be deemed to constitute public records, but shall be deemed and maintained by the board as confidential an…

A. Nothing in this Chapter shall be construed to require the mandatory testing of any practitioner for HBsAg or HIV seropositivity. Notes La. Admin. Code tit. 46 , § XLV-6715 Promulgated by the Department of Health and Hospitals, Board of Medical Examiners, LR 18:1126 (October 19…

A. Any violation of or failure of compliance with the provisions of this Subchapter, §§6901-6913, shall be deemed a violation of R.S. 37:1285 .A(6) and (29), providing cause for the board to suspend or revoke, refuse to issue, or impose probationary or other restrictions on any l…

A. The rules of this Subchapter govern physician responsibility for providing effective and safe pain control for patients with noncancer-related chronic or intractable pain. Notes La. Admin. Code tit. 46 , § XLV-6915 Promulgated by the Department of Health and Hospitals, Board o…

A. As used in this Subchapter, unless the content clearly states otherwise, the following terms and phrases shall have the meanings specified. Board - the Louisiana State Board of Medical Examiners. Chronic Pain - pain which persists beyond the usual course of a disease, beyond t…

A. The treatment of noncancer-related chronic or intractable pain with controlled substances constitutes legitimate medical therapy when provided in the course of professional medical practice and when fully documented in the patient's medical record. A physician duly authorized …

A. Requisite Prior Conditions. In utilizing any controlled substance for the treatment of noncancer-related chronic or intractable pain on a protracted basis, a physician shall comply with the following rules. 1. Evaluation of the Patient. Evaluation of the patient shall initiall…

A. Any violation of or failure of compliance with the provisions of this Subchapter, §§6915-6923, shall be deemed a violation of R.S. 37:1285 .A(6) and (14), providing cause for the board to suspend or revoke, refuse to issue, or impose probationary or other restrictions on any l…

A. The rules of this Subchapter provide for prescriber mandatory access and review of the Louisiana Prescription Monitoring Program, R.S. 40:1001 et seq., as from time-to-time may be amended (PMP), and for exceptions and noncompliance. Notes La. Admin. Code tit. 46 , § XLV-6931 P…

A. As used in this Subchapter, the following terms and phrases shall have the meanings specified. Administer- with respect to a medication provided or dispensed by a prescriber for use by a patient, the term administer means directly or through an agent to give, provide, or suppl…

A. Prior to initially prescribing any opioid to a patient, a prescriber or his/her delegate shall access and review the patients record in the PMP; and B. If opioids are prescribed to the patient for more than 90 days, the prescriber or his/her delegate shall access and review th…

A. For non-compliance with any of the provisions of this Subchapter the board may suspend, revoke, refuse to issue or impose probationary or other terms, conditions and restrictions on any license to practice in the state of Louisiana, or any registration issued under this Part, …

A. The rules of this Chapter govern physician use of integrative or complementary medicine in the treatment of patients. Notes La. Admin. Code tit. 46 , § XLV-7101 Promulgated by the Department of Health and Hospitals, Board of Medical Examiners, LR 28:1589 (July 2002). AUTHORITY…

A. As used in this Chapter, unless the content clearly states otherwise, the following terms and phrases shall have the meanings specified. Board - the Louisiana State Board of Medical Examiners. Controlled Substance - any substance defined, enumerated or included in federal or s…

A. The use of integrative or complementary medicine for the diagnosis or treatment of any illness, disease or condition, constitutes legitimate medical therapy when provided in the course of professional medical practice, complies with the standard of care applicable to conventio…

A. Any violation or failure of compliance with the provisions of this Chapter, shall be deemed unprofessional conduct and conduct in contravention of the board's rules, in violation of R.S. 37:1285 .A(13) and (30) respectively, as well as violation of any other applicable provisi…

A. Pursuant to Act 11 of the 2004 session of the Louisiana Legislature, the Louisiana Psychology Practice Act was amended to include, among other items, R.S. 37:2375 C(1), which provides: "A medical psychologist holding a valid certificate to prescribe shall prescribe only in con…

A. A physician shall only consult and collaborate with an MP provided such is performed in the course of his or her professional practice, documented in the patient's medical record, and in compliance with all of the requirements specified by this Chapter. Notes La. Admin. Code t…

A. A physician shall not consult and collaborate, as defined in § 7203 of these rules: 1. if the physician is no longer engaged in the clinical practice of medicine and the provision of patient care in this state; 2. on any patient for whom the physician is not the primary or att…

A. Consultation and Collaboration. Consultation and collaboration shall include discussion of any item the physician considers relevant to the coordination of the patient's medical care or evaluation of the psychopharmacologic management planned by the MP. The physician's consult…

A. A physician shall notify an MP and his patient in a timely manner that he or she has withdrawn or terminated concurrence if: 1. the physician determines that the medication prescribed is no longer appropriate or is contraindicated; 2. the physician receives information indicat…

A. A physician shall not consult and collaborate with an MP without the patient's written authorization as set forth in Subparagraph 7209.A.1. B. A physician shall insure that each of his or her patients subject to consultation and collaboration with an MP is informed: 1. of the …

A. A physician who consults and collaborates with a MP should report to the board all instances in which he or she has a good faith reason to believe that the MP has: 1. failed to consult with the primary or attending physician prior to prescribing medication or making any adjust…

A. Any violation or failure to comply with the provisions of this Chapter shall be deemed unprofessional conduct and conduct in contravention of the board's rules, in violation of R.S. 37:1285(A)(13) and (30) , respectively, as well as violation of any other applicable provision …

A. The rules of this Chapter govern the performance of office-based surgery by individuals licensed to practice medicine, including podiatry, in this state. Notes La. Admin. Code tit. 46 , § XLV-7301 Promulgated by the Department of Health and Hospitals, Board of Medical Examiner…

A. This Chapter shall not apply to the following surgical procedures or clinical settings: 1. exempt surgical procedures include those: a. that do not involve a drug induced alteration of consciousness and do not require the use of anesthesia or an anesthetic agent, those using o…

A. No physician shall perform office-based surgery except in compliance with the rules of this Chapter. B. The level of sedation utilized for office-based surgery shall be appropriate to the procedure. Under no circumstances shall a physician withhold appropriate sedation or unde…

A. Each physician or podiatric physician shall report to the board annually as a condition of the issuance or renewal of medical licensure, whether or not the physician performs or intends to perform office-based surgery. B. Each physician or podiatric physician who performs or i…

A. Level I 1. Level I office-based surgery includes, but is not limited to: a. minor procedures such as excision of skin lesions, moles, warts, cysts, lipomas, Loop Electrosurgical Excision Procedures (LEEP), laser cone of cervix, laser/cautery ablation of warts or other lesions,…

A. Evaluation of the Patient. All patients shall have a presurgical evaluation (history and physical) to screen for and identify any medical condition that could adversely affect the patient's response to the medications utilized for moderate or deep sedation. B. Diagnostic Testi…

A. A physician performing office-based surgery shall notify the board in writing within 15 days of the occurrence or receipt of information that an office-based surgery resulted in: 1. an unanticipated and unplanned transport of the patient from the facility to a hospital emergen…

A. Any violation or failure to comply with the provisions of this Chapter shall be deemed unprofessional conduct and conduct in contravention of the board's rules, in violation of R.S. 37:1285(A)(13) and (30) , respectively, as well as violation of any other applicable provision …

A. The rules of this Chapter govern the registration and practice of physicians engaged in collaborative drug therapy management with pharmacists in this state. Notes La. Admin. Code tit. 46 , § XLV-7401 Promulgated by the Department of Health and Hospitals, Board of Medical Exam…

A. As used in this Chapter, unless the content clearly states otherwise, the following terms and phrases shall have the meanings specified. Board - the Louisiana State Board of Medical Examiners, as constituted in the Medical Practice Act. Collaborative Drug Therapy Advisory Comm…

A. As used in this Chapter, the following terms and phrases shall have the meanings specified. Board -the Louisiana State Board of Medical Examiners , as established in R.S. 37:1261 - 1292 . Bona-Fide Physician-Patient Relationship -a relationship in which a physician : a. has co…